Asian Pacific journal of cancer prevention : APJCPHumansJapanAntiviral AgentsCarcinomaHepatocellular
Quantifying the Contribution of Viral Hepatitis Control Policies and Improvement of Hepatitis C Treatment in Japan during 2000-2030 based on Simulation Modelling.
Tomoyuki Akita, Junko Tanaka, Shinpei Imori, Kota Katanoda
Published: 202510.31557/APJCP.2025.26.10.3513
Abstract
INTRODUCTION: Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major causes of hepatocellular carcinoma (HCC) in Japan. The Japanese government has implemented various countermeasures since the early 2000s, including expande…
Preview only. Read the full abstract at the source